Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Sodium intake is associated with increased disease activity in multiple sclerosis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Astrocytes in multiple sclerosis.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
[The biological role of sulfatides].
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Co-occurrence of multiple sclerosis and Parkinson disease.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Papers: 5 Feb 2016 - 12 Feb 2016
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
ECTRIMS 2013 Day 2
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.

Pages